Kellogg's
Coverage of Kellogg's in the Nexus archive.
- David Protein CEO says ‘diet trends are over’ because of GLP-1s: ‘What’s next is really hard to predict’
David Protein CEO Peter Rahal claims GLP-1 receptor agonists are ending traditional diet trends, citing their impact on appetite regulation and weight loss. Food companies like Nestle and Conagra are adapting by creating products for GLP-1 users, while David Protein capitalizes on 'proteinmaxxing' to meet demand for high-protein snacks. The rise of GLP-1 medications has disrupted weight loss programs, contributing to WeightWatchers' bankruptcy and a shift in food industry priorities.
- Big Short legend Steve Eisman says everyone is buying the wrong AI stocks
Steve Eisman criticizes SpaceX's stock valuation, comparing its revenue to Kellogg's while noting no company of its size has ever been valued at over 100x revenue. He highlights asteroid mining plans in SpaceX's S-1 filing and contrasts this with the fictional context of Apple TV's 'For All Mankind.' Eisman, known for shorting the 2006-2007 housing bubble, argues hype and sci-fi-inspired ambitions are distorting market valuations.